Similar articles for PMID: 17327290

Year	Number of Results
1983	1
1992	1
1999	1
2000	2
2001	1
2002	4
2003	4
2004	6
2005	8
2006	3
2007	13
2008	11
2009	8
2010	8
2011	7
2012	3
2015	1
2016	1
2017	2
2019	1
2020	1
2021	3
2022	2
2024	0

1

Elevated creatine kinase and myalgia in a patient taking rosiglitazone.

Kennie N, Antoniou T, Berger P. Kennie N, et al. Ann Pharmacother. 2007 Mar;41(3):521-4. doi: 10.1345/aph.1h609. Epub 2007 Feb 27. Ann Pharmacother. 2007. PMID: 17327290

2

Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone.

Ledl M, Hohenecker J, Francesconi C, Roots I, Bauer MF, Roden M. Ledl M, et al. Diabetologia. 2005 Oct;48(10):1996-8. doi: 10.1007/s00125-005-1919-8. Epub 2005 Aug 17. Diabetologia. 2005. PMID: 16132947

3

Second-generation thiazolidinediones and hepatotoxicity.

Marcy TR, Britton ML, Blevins SM. Marcy TR, et al. Ann Pharmacother. 2004 Sep;38(9):1419-23. doi: 10.1345/aph.1E072. Epub 2004 Jul 20. Ann Pharmacother. 2004. PMID: 15266041

4

Creatine kinase elevation, lactacidemia, and metabolic myopathy in adult patients with diabetes mellitus.

Frank M, Finsterer J. Frank M, et al. Endocr Pract. 2012 May-Jun;18(3):387-93. doi: 10.4158/EP11316.OR. Endocr Pract. 2012. PMID: 22297056

5

Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma.

El-Naggar MH, Helmy A, Moawad M, Al-Omary M, Al-Kadhi Y, Habib B. El-Naggar MH, et al. Ann Pharmacother. 2008 May;42(5):713-8. doi: 10.1345/aph.1K543. Epub 2008 Apr 8. Ann Pharmacother. 2008. PMID: 18397974

6

Gemfibrozil-induced myositis in a patient with normal renal function.

Hahn M, Sriharan K, McFarland MS. Hahn M, et al. Ann Pharmacother. 2010 Jan;44(1):211-4. doi: 10.1345/aph.1M411. Epub 2009 Nov 24. Ann Pharmacother. 2010. PMID: 19934390

7

Hepatic injury in a patient taking rosiglitazone.

Menees SB, Anderson MA, Chensue SW, Moseley RH. Menees SB, et al. J Clin Gastroenterol. 2005 Aug;39(7):638-40. doi: 10.1097/01.mcg.0000170768.59696.16. J Clin Gastroenterol. 2005. PMID: 16000935

8

Severe HDL-c reduction during rosiglitazone therapy in an obese woman with type 2 diabetes.

Almeida RL, Fedrizzi P, Fedrizzi D, Almeida TS. Almeida RL, et al. Arq Bras Endocrinol Metabol. 2010 Oct;54(7):663-7. doi: 10.1590/s0004-27302010000700012. Arq Bras Endocrinol Metabol. 2010. PMID: 21085773

9

Muscle pain associated with daptomycin.

Veligandla SR, Louie KR, Malesker MA, Smith PW. Veligandla SR, et al. Ann Pharmacother. 2004 Nov;38(11):1860-2. doi: 10.1345/aph.1D639. Epub 2004 Sep 14. Ann Pharmacother. 2004. PMID: 15367725

10

Cardiovascular risk of rosiglitazone: another perspective.

Waksman JC. Waksman JC. J Pharm Pharmacol. 2008 Dec;60(12):1573-82. doi: 10.1211/jpp.60.12.0002. J Pharm Pharmacol. 2008. PMID: 19000361 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year